ChartRow logo
GH
Guardant Health Inc.Stock · Health Care · Russell 2000 0.4%
$159.62−$5.50 (-3.33%)as of market close, Aug 13, 2026
☾ After hours:$159.54+0.00%3:59 PM ET
CompareLLYUNHJNJABBVISRGTMO

GHGuardant Health Inc. stock price, chart and key statistics

Key stats#

Price data

Price
$159.62
Change YTD
+56.27%
Market cap
21.4B
Enterprise value
22.1B
Shares outstanding
134.2M
52W low
$53.40
52W high
$176.58
From 52W high
-9.61%
From 52W low
+198.90%
52W range
86%
Beta
1.57

Volume

Rel volume
0.70×
30D volume
2.1M
30D $ vol
335.9M

Fundamentals

Sales (ttm)
1.2B
Sales/share
$8.82
EPS (ttm)
-$3.50
FCF (ttm)
-240.7M
FCF/share
$-1.79
Book value/share
$-1.66
Net margin
-38.33%
ROA
-23.71%
Current ratio
4.03

Growth (CAGR, ttm) · 10Y

Sales
+49.96%
Net income
n/a
FCF
n/a
Shares
n/a

Per-share growth (CAGR, ttm) · 10Y

EPS
n/a
Sales/share
n/a
FCF/share
n/a
Book value/share
n/a
Price
n/a
Total return
n/a

Fundamentals end at the last reported quarter; price and total return end at the latest close.

Valuation

Fwd P/E
-374.1×
18.1×
-96.1×
EV/Sales (ttm)
18.6×
-1.12%
-7.62%
-7.62%
-1.20%
-1.20%

Vs own 10Y history

P/S
56th
P/B
97th

Bar = where today's multiple sits in GH's own 10-year range:near a decade-low (cheap)near a decade-high (rich).

Performance · price return#

1D
-3.33%
1W
+1.29%
1M
-2.05%
3M
+62.10%
YTD
+56.27%
1Y
+189.68%
5Y
+38.33%

Financial statements

Open full GH financials →
1M
TickerThemePrice1M30D $Vol
NVS
Novartis AG
Health Care$152+0.59%268.9M
NVO
Novo Nordisk A/S
Health Care$46.73-7.58%555.7M
GSK
GSK plc American Depositary Shares (Each representing two Ordinary Shares)
Health Care$50.46-1.92%212.8M
SNY
Sanofi ADS
Health Care$43.78+0.23%142.5M
TAK
Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock)
Health Care$17.41+5.84%65M
ARGX
argenx SE American Depositary Shares
Health Care$857-0.66%251.9M
NTRA
Natera Inc.
Health Care$311+12.05%362.2M
RVMD
Revolution Medicines Inc.
Health Care$202+9.48%351.3M

Guardant Health Inc. (GH) trades at $159.62 with a live price and an interactive chart covering 7+ years of daily price history, plus key valuation metrics. ChartRow also publishes GH's financial statements free — annual and quarterly income statement, balance sheet, and cash flow straight from SEC filings, with P/E and valuation history and dividend data. See full GH financial statements →